Deloitte Corporate Finance LLC advises FarrowMed, LLC (dba FarrowMed) on its sale to BSN Medical, Inc.
CHARLOTTE, N.C, August 11, 2015 — Deloitte Corporate Finance LLC (DCF) acted as exclusive financial advisor to FarrowMed, LLC (FarrowMed) on its sale to BSN Medical, Inc. (BSN).
Founded in 2004 by Dr. Wade Farrow and Dr. Barry Creighton in Bryan, Texas, FarrowMed develops and manufactures compression garments used in the treatment of a variety of medical conditions. Its innovative garment technology is protected by patented intellectual property.
“DCF did an excellent job managing the sale process for us. Their understanding of the compression garments and medical devices landscape was key to the successful outcome of this process. We are excited to expand the FarrowMed platform in partnership with BSN,” said Dr. Wade Farrow, founder and co-owner of FarrowMed.
“By leveraging our industry insight and helping to create a competitive bidding process, we assisted FarrowMed in achieving their strategic objectives. We look forward to seeing FarrowMed’s garment technology’s future within BSN and continuing to grow our compression garments practice,” said Tom Spivey, managing director, Deloitte Corporate Finance LLC.
FarrowMed is a global leader in Elastic Short-StretchTM compression garments for lymphoedema, venous disease, and other acute and chronic oedemas. The company is focused on innovative medical solutions to provide cost effective treatments to improve patient care. The FarrowWrap® is a trusted compression solution with over 100,000 sold and represents a gold standard in treating stubborn lymphoedema. In addition, FarrowMed has a strong intellectual property portfolio and holds 19 patents with more pending.
BSN medical is a global leader in wound care and related vascular diseases, lymphology and non-invasive orthopaedic products. Founded in 2001, the company currently employs approximately 5,500 members of staff and generated revenues of € 762m in 2014. The company aims to provide an integrated therapy-driven approach–grounded in a broad portfolio of products, enhanced by insights into current therapeutic areas and complemented by a progressive approach to partnerships. Its well-known brands such as Leukoplast®, Cutimed®, JOBST, Delta® and Actimove® are among the most trusted in healthcare. With its comprehensive product portfolio, BSN medical addresses patients’ needs in the most prevalent conditions in wound care and vascular diseases, and orthopaedic treatments. For more information visit www.bsnmedical.com.
About Deloitte Corporate Finance LLC
Deloitte Corporate Finance LLC provides strategic advisory services and M&A advice that help corporate, entrepreneurial and private equity clients create and act upon opportunities for liquidity, growth and long-term advantage. With an in-depth understanding of the marketplace and access to a global network of investment bankers, we help clients confidently pursue strategic transactions in both domestic and global markets. DCF, together with the Corporate Finance Advisory practices within the Deloitte Touche Tohmatsu Limited network of member firms, include in excess of 1,900 professionals, who work collaboratively across 150 international locations. With our significant experience providing investment banking services across key industries, we are able to offer our clients solutions that help them to achieve their strategic objectives. For more information, visit www.investmentbanking.deloitte.com.
Prior engagement performance is no guarantee of future performance and may not be representative of the experience of other clients. This communication is for informational purposes only and is not intended as an offer or solicitation for the purchase or sale of a security.
Deloitte Corporate Finance LLC, an SEC registered broker-dealer and member of FINRA and SIPC, is an indirect wholly-owned subsidiary of Deloitte Financial Advisory Services LLP and affiliate of Deloitte Transactions and Business Analytics LLP. Investment banking products and services within the United States are offered exclusively through Deloitte Corporate Finance LLC. For more information, visit www.investmentbanking.deloitte.com. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.